1. Review timelines for applicant responses to complete response letters when a facility assessment is needed during the COVID-19 public health emergency Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, December 2020 Subject(s): Correspondence as TopicDrug ApprovalDrug IndustryFacility Regulation and ControlCOVID-19United StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration